Intellia Therapeutics Stock Forecast - Simple Moving Average
| NTLA Stock | USD 15.41 0.20 1.31% |
The Simple Moving Average forecasted value of Intellia Therapeutics on the next trading day is expected to be 15.41 with a mean absolute deviation of 0.72 and the sum of the absolute errors of 42.52. Intellia Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Intellia Therapeutics stock prices and determine the direction of Intellia Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Intellia Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Intellia |
Open Interest Against 2024-12-20 Intellia Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Intellia Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Intellia Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Intellia Therapeutics stock based on available contracts left at the end of a trading day.
No Open InterestPlease note that to derive more accurate forecasting about market movement from the current Intellia Therapeutics' open interest, investors have to compare it to Intellia Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Intellia Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Intellia. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Intellia Therapeutics Simple Moving Average Price Forecast For the 30th of November
Given 90 days horizon, the Simple Moving Average forecasted value of Intellia Therapeutics on the next trading day is expected to be 15.41 with a mean absolute deviation of 0.72, mean absolute percentage error of 1.00, and the sum of the absolute errors of 42.52.Please note that although there have been many attempts to predict Intellia Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Intellia Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Intellia Therapeutics Stock Forecast Pattern
| Backtest Intellia Therapeutics | Intellia Therapeutics Price Prediction | Buy or Sell Advice |
Intellia Therapeutics Forecasted Value
In the context of forecasting Intellia Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Intellia Therapeutics' downside and upside margins for the forecasting period are 11.00 and 19.82, respectively. We have considered Intellia Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Intellia Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Intellia Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.4359 |
| Bias | Arithmetic mean of the errors | 0.1114 |
| MAD | Mean absolute deviation | 0.7208 |
| MAPE | Mean absolute percentage error | 0.042 |
| SAE | Sum of the absolute errors | 42.525 |
Predictive Modules for Intellia Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intellia Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Intellia Therapeutics
For every potential investor in Intellia, whether a beginner or expert, Intellia Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Intellia Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Intellia. Basic forecasting techniques help filter out the noise by identifying Intellia Therapeutics' price trends.Intellia Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intellia Therapeutics stock to make a market-neutral strategy. Peer analysis of Intellia Therapeutics could also be used in its relative valuation, which is a method of valuing Intellia Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Intellia Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Intellia Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Intellia Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Intellia Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Intellia Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intellia Therapeutics shares will generate the highest return on investment. By undertsting and applying Intellia Therapeutics stock market strength indicators, traders can identify Intellia Therapeutics entry and exit signals to maximize returns.
Intellia Therapeutics Risk Indicators
The analysis of Intellia Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Intellia Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting intellia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.2 | |||
| Standard Deviation | 4.36 | |||
| Variance | 18.98 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Intellia Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intellia Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intellia Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intellia Therapeutics Stock:Check out Historical Fundamental Analysis of Intellia Therapeutics to cross-verify your projections. For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intellia Therapeutics. If investors know Intellia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intellia Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.45) | Revenue Per Share 0.449 | Quarterly Revenue Growth (0.24) | Return On Assets (0.28) | Return On Equity (0.52) |
The market value of Intellia Therapeutics is measured differently than its book value, which is the value of Intellia that is recorded on the company's balance sheet. Investors also form their own opinion of Intellia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Intellia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intellia Therapeutics' market value can be influenced by many factors that don't directly affect Intellia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intellia Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Intellia Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intellia Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.